Citations (51)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Guofeng Chen, Wei Zhou, Dan Gong, Yan Li, Sai Huang, Nan Wang, Qingyu Xu, Qian Xiong, Yu Jing, Na Lv, Lili Wang, Yonghui Li & Li Yu. (2020) Loss of X chromosome predicts favorable prognosis in female patients with t(8;21) acute myeloid leukemia. Leukemia & Lymphoma 61:5, pages 1168-1177.
Read now
Read now
Wei Zhou, Guofeng Chen, Dan Gong, Yan Li, Sai Huang, Nan Wang, Qingyu Xu, Qian Xiong, Yu Jing, Na Lv, Lili Wang, Yonghui Li & Li Yu. (2020) Loss of the Y chromosome predicts a high relapse risk in younger adult male patients with t(8;21) acute myeloid leukemia on high-dose cytarabine consolidation therapy: a retrospective multicenter study. Leukemia & Lymphoma 61:4, pages 820-830.
Read now
Read now
Russell C. DeKelver, Benjamin Lewin, Stephanie Weng, Ming Yan, Joseph Biggs & Dong-Er Zhang. (2014) RUNX1–ETO induces a type I interferon response which negatively effects t(8;21)-induced increased self-renewal and leukemia development. Leukemia & Lymphoma 55:4, pages 884-891.
Read now
Read now
DR Barnard & WG Woods. (2005) Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer – An update. Leukemia & Lymphoma 46:5, pages 651-663.
Read now
Read now
Joëlle Michaud, Hamish S. Scott & Robert Escher. (2003) AML1 Interconnected Pathways of Leukemogenesis. Cancer Investigation 21:1, pages 105-136.
Read now
Read now
Articles from other publishers (46)
Sarah Javed, Jawad Hassan, Maliha Naz, Saira Shan, Madiha Abid & Tahir Sultan Shamsi. (2023) Cytogenetic culture failure and its causes in hematological disorders; a single centre perspective. Molecular Cytogenetics 16:1.
Crossref
Crossref
Weiyun Jiao, Yuanyuan Liu & Yangyi Bao. (2022) Clinical Significance of EZH2 in Acute Myeloid Leukemia. Computational Intelligence and Neuroscience 2022, pages 1-5.
Crossref
Crossref
Biao Wang, Lijun Wen, Zheng Wang, Suning Chen & Huiying Qiu. (2022) Differential Implications of CSF3R Mutations in t(8;21) and CEBPA Double Mutated Acute Myeloid Leukemia. Clinical Lymphoma Myeloma and Leukemia 22:6, pages 393-404.
Crossref
Crossref
Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies
301
427
.
Biao Wang, Bin Yang, Yun Ling, Jihong Zhang, Xiaoying Hua, Weiying Gu & Feng Yan. (2020) Role of CD19 and specific KIT‐D816 on risk stratification refinement in t(8;21) acute myeloid leukemia induced with different cytarabine intensities. Cancer Medicine 10:3, pages 1091-1102.
Crossref
Crossref
Neelum Mansoor, Naeem Jabbar, Uzma Arshad, Sidra Maqsood, Muhammad A. Habib & Muhammad R. Raza. (2020) Outcome of Core Binding Factor Acute Myeloid Leukemia in Children: A Single-Center Experience. Journal of Pediatric Hematology/Oncology 42:6, pages e423-e427.
Crossref
Crossref
Ruchi Gupta, Sanjeev Yadav, Yatendra Parashar, Khaliqur Rahman, Manish Kumar Singh, Dinesh Chandra, Anshul Gupta & Soniya Nityanand. (2019)
Morphological characteristics, cytogenetic profile, and outcome of
RUNX1‐RUNX1T1
‐positive acute myeloid leukemia: Experience of an Indian tertiary care center
. International Journal of Laboratory Hematology 42:1, pages 37-45.
Crossref
Crossref
Biao Wang, Jihong Zhang, Xiaoying Hua, Haiqian Li, Zhilin Wang & Bin Yang. (2020) Clinical heterogeneity under induction with different dosages of cytarabine in core binding factor acute myeloid leukaemia. Scientific Reports 10:1.
Crossref
Crossref
Akihiro Abe, Yukiya Yamamoto, Akira Katsumi, Akinao Okamoto, Masutaka Tokuda, Yoko Inaguma, Kiyoko Yamamoto, Masamitsu Yanada, Tadaharu Kanie, Akihiro Tomita, Yoshiki Akatsuka, Masataka Okamoto, Toshiki Kameyama, Akila Mayeda & Nobuhiko Emi. (2017) Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1–RUNX1T1 leukemia with t(8;12;21). International Journal of Hematology 108:2, pages 208-212.
Crossref
Crossref
Jean-Baptiste Micol, Alessandro Pastore, Daichi Inoue, Nicolas Duployez, Eunhee Kim, Stanley Chun-Wei Lee, Benjamin H. Durham, Young Rock Chung, Hana Cho, Xiao Jing Zhang, Akihide Yoshimi, Andrei Krivtsov, Richard Koche, Eric Solary, Amit Sinha, Claude Preudhomme & Omar Abdel-Wahab. (2017) ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia. Nature Communications 8:1.
Crossref
Crossref
Barbara J. Bain. 2017. Leukaemia Diagnosis. Leukaemia Diagnosis
135
248
.
Qiuhua Zhu, Lingxiu Zhang, Xiaodong Li, Fang Chen, Ling Jiang, Guopan Yu, Zhixiang Wang, Changxin Yin, Xuejie Jiang, Qingxiu Zhong, Hongsheng Zhou, Bingjie Ding, Chunli Wang & Fanyi Meng. (2016) Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia. Tumor Biology 37:8, pages 11409-11420.
Crossref
Crossref
Dan Gong, Wei Li, Liang-Ding Hu, Jian-Liang Shen, Mei-Yun Fang, Qing-Ming Yang, Heng-Xiang Wang, Xiao-Yan Ke, Hui-Ren Chen, Zhao Wang, Hui Liu, Feng Liu, Yi-Gai Ma, Jing-Wen Wang, Hong-Hua Li, Quan-Shun Wang, Yu Jing, Xiao-Ning Gao, Li-Ping Dou, Yong-Hui Li, Jian-Min Luo & Li Yu. (2016) Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China. Acta Haematologica 136:4, pages 201-209.
Crossref
Crossref
Kim KleinGertjan KaspersChristine J. HarrisonH. Berna BeverlooArdine ReedijkMathilda BongersJacqueline CloosAndrea PessionDirk ReinhardtMartin ZimmermanUrsula CreutzigMichael DworzakTodd AlonzoDonna JohnstonBetsy HirschMichal ZapotockyBarbara De MoerlooseAlcira FynnVincent LeeTakashi TagaAkio TawaAnne AuvrignonBernward ZellerErik ForestierCarmen SalgadoWalentyna BalwierzAlexander PopaJeffrey RubnitzSusana RaimondiBrenda Gibson. (2015)
Clinical Impact of Additional Cytogenetic Aberrations,
cKIT
and
RAS
Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group
. Journal of Clinical Oncology 33:36, pages 4247-4258.
Crossref
Crossref
Yongcheng Benjamin Tan. (2015) Myeloid Sarcoma Masquerading as Granulation Tissue. International Journal of Surgical Pathology 23:7, pages 553-556.
Crossref
Crossref
Melhem Solh, Sophia Yohe, Daniel Weisdorf & Celalettin Ustun. (2014) Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy. American Journal of Hematology 89:12, pages 1121-1131.
Crossref
Crossref
Russell C. DeKelver, Benjamin Lewin, Kentson Lam, Yukiko Komeno, Ming Yan, Chandler Rundle, Miao-Chia Lo & Dong-Er Zhang. (2013) Cooperation between RUNX1-ETO9a and Novel Transcriptional Partner KLF6 in Upregulation of Alox5 in Acute Myeloid Leukemia. PLoS Genetics 9:10, pages e1003765.
Crossref
Crossref
Russell C. DeKelverMing YanEun-Young AhnWei-Jong ShiaNancy A. Speck & Dong-Er Zhang. (2013) Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential. Blood 121:18, pages 3714-3717.
Crossref
Crossref
Claudio Ortolani. 2011. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies
1
157
.
Robert B. Lorsbach. 2011. Diagnostic Pediatric Hematopathology. Diagnostic Pediatric Hematopathology
272
309
.
M. Crovetto, J. A. Márquez, C. Ereño, J. Elexpuru, R. Crovetto & A. Martinez. (2011) Granulocytic Sarcoma Presenting as Atypical Mastoiditis with Facial Paralysis: Description of a Case. Case Reports in Otolaryngology 2011, pages 1-3.
Crossref
Crossref
Sook Young Bae, Jang Su Kim, Bung Jun Ryeu, Kap No Lee, Chang Kyu Lee, Young Kee Kim, Chae Seung Lim, Yunjung Cho, Chul Won Choi, Sook-Won Ryu & Soo-Young Yoon. (2010) Acute myeloid leukemia (AML-M2) associated with variant t(8;21): report of three cases. Cancer Genetics and Cytogenetics 199:1, pages 31-37.
Crossref
Crossref
Barbara J. Bain. 2010. Leukaemia Diagnosis. Leukaemia Diagnosis
114
218
.
Huan-You Wang & Carlos A. Tirado. (2010) t(8;21)(q22;q22) Translocation involving AML1 and ETO in B lymophoblastic leukemia. Human Pathology 41:2, pages 286-292.
Crossref
Crossref
Jennifer J. D. Morrissette, Karen Weck & Cherie H. Dunphy. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases
129
152
.
Kyoung-Jin Park, Hyung-Doo Park, Hee-Jin Kim, Keon Hee Yoo, Hong Hoe Koo & Sun-Hee Kim. (2009) A novel four-way t(6;16;21;8)(p21.3;p11.2;q22;q22) in acute myeloid leukemia with RUNX1/RUNX1T1 rearrangement. Cancer Genetics and Cytogenetics 192:2, pages 90-92.
Crossref
Crossref
Steven A. Gustafson, Pei Lin, Su S. Chen, Lei Chen, Lynne V. Abruzzo, Rajyalakshmi Luthra, L. Jeffrey Medeiros & Sa A. Wang. (2009) Therapy-Related Acute Myeloid Leukemia With t(8;21) (q22;q22) Shares Many Features With De Novo Acute Myeloid Leukemia With t(8;21)(q22;q22) but Does Not Have a Favorable Outcome. American Journal of Clinical Pathology 131:5, pages 647-655.
Crossref
Crossref
Eun-Young AhnMing YanOxana A. MalakhovaMiao-Chia LoAnita BoyapatiHans Beier Ommen, Robert HinesPeter Hokland & Dong-Er Zhang. (2008) Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis. Proceedings of the National Academy of Sciences 105:44, pages 17103-17108.
Crossref
Crossref
Pei Lin, Lei Chen, Rajyalakshmi Luthra, Sergej N Konoplev, Xuemei Wang & L Jeffrey Medeiros. (2008) Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations. Modern Pathology 21:8, pages 1029-1036.
Crossref
Crossref
Prajakta Kokate, Firoz Ahmad, Rupa Dalvi, Bibhu Ranjan Das & Swarna Mandava. (2008) Molecular cytogenetic investigations in a novel complex variant of t(8;21)(q22;q22) with ins(15;21)(q15;q22.2q22.3) in a patient with AML-M2 subtype. Cancer Genetics and Cytogenetics 184:1, pages 52-56.
Crossref
Crossref
S.-W. CHEN, C.-F. LI, S.-S. CHUANG, C.-C. TZENG, Y.-C. HSIEH, P.-S. LEE, C.-H. CHEN, W.-T. HUANG, W.-S. HWANG & C.-J. TSAO. (2008) Aberrant co-expression of CD19 and CD56 as surrogate markers of acute myeloid leukemias with t(8;21) in Taiwan. International Journal of Laboratory Hematology 30:2, pages 133-138.
Crossref
Crossref
Richard F. Schlenk, Marcelo C. Pasquini, Waleska S. Pérez, Mei-Jie Zhang, Jürgen Krauter, Joseph H. Antin, Asad Bashey, Brian J. Bolwell, Thomas Büchner, Jean-Yves Cahn, Mitchell S. Cairo, Edward A. Copelan, Corey S. Cutler, Hartmut Döhner, Robert Peter Gale, Osman Ilhan, Hillard M. Lazarus, Jane L. Liesveld, Mark R. Litzow, David I. Marks, Richard T. Maziarz, Philip L. McCarthy, Stephen D. Nimer, Jorge Sierra, Martin S. Tallman, Daniel J. Weisdorf, Mary M. Horowitz & Arnold Ganser. (2008) HLA-Identical Sibling Allogeneic Transplants versus Chemotherapy in Acute Myelogenous Leukemia with t(8;21) in First Complete Remission: Collaborative Study between the German AML Intergroup and CIBMTR. Biology of Blood and Marrow Transplantation 14:2, pages 187-196.
Crossref
Crossref
Keiki Kawakami, Kazuhiro Nishii, Ryuu Hyou, Yasuyuki Watanabe, Makoto Nakao, Hidetsugu Mitani, Tetsuya Murata, Fumihiko Monma, Shunji Yamamori, Noboru Hosokai & Ikuo Miura. (2007) A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22). International Journal of Hematology 87:1, pages 78-82.
Crossref
Crossref
Stein and Anthony & Forman J. Stephen. 2008. Hematopoietic Stem Cell Transplantation. Hematopoietic Stem Cell Transplantation
57
82
.
Anita BoyapatiMing YanLuke F. PetersonJoseph R. BiggsMichelle M. Le Beau & Dong-Er Zhang. (2006) A leukemia fusion protein attenuates the spindle checkpoint and promotes aneuploidy. Blood 109:9, pages 3963-3971.
Crossref
Crossref
Elpis Mantadakis, Vassiliki Danilatou, Eftichia Stiakaki, George Paterakis, Stefanos Papadhimitriou & Maria Kalmanti. (2007) T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia. Pediatric Blood & Cancer 48:3, pages 354-357.
Crossref
Crossref
Frederick R. Appelbaum, Kenneth J. Kopecky, Martin S. Tallman, Marilyn L. Slovak, Holly M. Gundacker, Haesook T. Kim, Gordon W. Dewald, Hagop M. Kantarjian, Sherry R. Pierce & Elihu H. Estey. (2006) The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations. British Journal of Haematology 135:2, pages 165-173.
Crossref
Crossref
Jose R. Valbuena, L. Jeffrey Medeiros, George Z. Rassidakis, Suyang Hao, C. Daniel Wu, Lei Chen & Pei Lin. (2006) Expression of B Cell–Specific Activator Protein/PAX5 in Acute Myeloid Leukemia With t(8;21)(q22;q22). American Journal of Clinical Pathology 126:2, pages 235-240.
Crossref
Crossref
Ming Yan, Eiki Kanbe, Luke F Peterson, Anita Boyapati, Yuqin Miao, Yang Wang, I-Ming Chen, Zixing Chen, Janet D Rowley, Cheryl L Willman & Dong-Er Zhang. (2006) A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nature Medicine 12:8, pages 945-949.
Crossref
Crossref
Liming Bao, Xiaoqin Wang, John Ryder, Meirong Ji, Yan Chen, Hui Chen, Hengjuan Sun, Yongchen Yang, Xinyu Du, Patrick Kerzic, Sherilyn A. Gross, Lihong Yao, Ling Lv, Hua Fu, Guowei Lin & Richard D. Irons. (2006) Prospective study of 174 de novo acute myelogenous leukemias according to the WHO classification: subtypes, cytogenetic features and FLT3 mutations. European Journal of Haematology 77:1, pages 35-45.
Crossref
Crossref
Daniel Catovsky & John Swansbury. (2005) Del(9q) acute myeloid leukaemia: clinical and cytological characteristics and prognostic implications. British Journal of Haematology 130:6, pages 969-969.
Crossref
Crossref
A. J. Peniket. (2005) Del(9q) acute myeloid leukaemia: clinical and cytological characteristics and prognostic implications - response to Catovsky and Swansbury. British Journal of Haematology 130:6, pages 969-969.
Crossref
Crossref
Hui-Hua Hsiao, Goro Sashida, Atsushi Kodama, Katsuhiro Fukutake & Kazuma Ohyashiki. (2005) Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia. Cancer Genetics and Cytogenetics 159:1, pages 96-97.
Crossref
Crossref
Ming Yan, Sebastien A. Burel, Luke F. Peterson, Eiki Kanbe, Hiromi Iwasaki, Anita Boyapati, Robert Hines, Koichi Akashi & Dong-Er Zhang. (2004) Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development. Proceedings of the National Academy of Sciences 101:49, pages 17186-17191.
Crossref
Crossref
Christa Fonatsch, Ilse Schwarzinger, Gerlinde Mitterbauer, Ulrich Jäger, Rotraud Wieser, Christine Mannhalter & Klaus Lechner. 2003. Molekularmedizinische Grundlagen von hämatologischen Neoplasien. Molekularmedizinische Grundlagen von hämatologischen Neoplasien
312
350
.
Kinuyo Kaneda, Kensuke Kojima, Makoto Takeuchi, Hidetaka Takimoto, Seiji Takaba, Katsuji Shinagawa, Hajime Kobayashi, Akira Miyata, Masamichi Hara & Mitsune Tanimoto. (2002) Can t(8;21) oligoblastic leukemia be called a myelodysplastic syndrome?. European Journal of Haematology 69:3, pages 165-170.
Crossref
Crossref